Clinical Trial Update: 2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating 2.5% and 10% phenylephrine for mydriasis in diabetic patients with darkly pigmented irides has completed. The study was sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• phenylephrine ophthalmic solution (phenylephrine)

Snippet

Sponsor: Khon Kaen University | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED